Screener
Ionis Pharmaceuticals IONS Ionis Operations — Selling General And Administrative Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Drug discovery | 29,120 | 30,255 | 57,677 | 57,244 |
| Drug development | 103,958 | 117,689 | 208,140 | 230,635 |
| Medical affairs | 11,318 | 7,826 | 21,307 | 13,468 |
| Manufacturing and development chemistry | 20,639 | 21,545 | 40,947 | 35,826 |
| R&D support | 26,974 | 20,607 | 49,405 | 41,159 |
| Selling, general and administrative | 130,075 | 81,081 | 262,012 | 148,061 |
| Other segment items (1) | 57,948 | 45,954 | 76,330 | 75,750 |
| Consolidated net income (loss) | $$(114,646) | $123,551 | $(207,174) | (23,387) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's ionis operations — selling general and administrative expense?
- Ionis Pharmaceuticals (IONS) reported ionis operations — selling general and administrative expense of $130.08M in Q2 2026.
- How has Ionis Pharmaceuticals's ionis operations — selling general and administrative expense changed year-over-year?
- Ionis Pharmaceuticals's ionis operations — selling general and administrative expense increased by 60.4% year-over-year, from $81.08M to $130.08M.
- What is the long-term trend for Ionis Pharmaceuticals's ionis operations — selling general and administrative expense?
- Over 3 years (2022 to 2025), Ionis Pharmaceuticals's ionis operations — selling general and administrative expense has grown at a 41.5% compound annual growth rate (CAGR), from $124.37M to $351.99M.
- What does ionis operations — selling general and administrative expense mean?
- This includes the costs of commercial operations, marketing, legal, finance, and other corporate functions necessary to run the business. It measures the operational overhead and commercial infrastructure required to support the company's market presence.
Ask your AI about Ionis Pharmaceuticals's ionis operations — selling general and administrative expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude